Douglas Schumer, MD
Corneal and Contact Management · Mansfield, OHNPI 1205838943
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $3,050 of the $4,333 with a category attached, or 70.4%. Bausch & Lomb, A Division Of Bausch Health US, LLC accounts for 75.6% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2021 at $3,105 and has fallen 97.9% since, to $64 in 2025. Among corneal and contact management clinicians in OH with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 46 payments — averaging $94.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bausch & Lomb, A Division Of Bausch Health US, LLC$3K
- Bausch & Lomb Americas Inc.$337
- Alcon$245
- Lombart Brothers, Inc.$203
- Biotissue Holdings Inc.$108
- Rxsight Inc$49
- plus $113 from 3 others
What the payments were for
- Consulting fees$3,05070%
- Food & beverage$1,28330%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 7 | $3,277 |
| Bausch & Lomb Americas Inc. | 7 | $337 |
| Alcon | 12 | $245 |
| Lombart Brothers, Inc. | 7 | $203 |
| Biotissue Holdings Inc. | 3 | $108 |
| Rxsight Inc | 2 | $49 |
| AbbVie(2 entities) | 3 | $41 |
| Shire North American Group Inc | 3 | $40 |
| Johnson & Johnson Surgical Vision, Inc. | 2 | $31 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VICTUS$3,168
- IC-8 Apthera IOL$147
How this compares
$4,333 in reported general payments places this provider in the 90th percentile of 40 corneal and contact management providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 218 | $10,411 |
| Brimonidine Tartrate | 22 | $1,473 |
| Ofloxacin | 76 | $872 |
| Ketorolac Tromethamine | 14 | $267 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 31 | $151 |
| Timolol Maleate | 12 | $116 |
Paid to pharmacies, not to this prescriber.
Other corneal and contact management in Mansfield
- Tonya LindsellCincinnati$30K
- Lori YeagleCincinnati$12K
- Denise BellColumbus$6K
- Andrea EarleyTwinsburg$4K
- Ann KurzerCincinnati$4K
- Steven HansenMassillon$4K
- Thomas BobstNorth Olmsted$4K
- Deborah ValidoCincinnati$3K
- James AmundsonCanton$2K
- Joseph MarraToledo$878
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.